Clinical Trial

Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The researchers are doing this study to see if having immediate lymphatic reconstruction after axillary lymph node dissection (ALND) can decrease the development of lymphedema, a side effect of ALND. Other purposes of the study include: Comparing the approach of immediate lymphatic reconstruction after ALND with the approach of ALND alone Looking at whether having immediate lymphatic reconstruction after ALND improves a person's quality of life Seeing if adding standard of care radiation therapy to either study approach (immediate lymphatic reconstruction after ALND or ALND alone) has an effect on development of lymphedema
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2020-01-24; most recent amendment 2026-02-25.
Status change: Recruiting → Active, Not Recruiting 2023-12-20
Trial Details
NCT Number NCT04241341
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Breast Cancer Lymphedema
Enrollment 180 participants
Start Date 2020-01-22
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-27